Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Role of biologics in first-line treatment of colorectal cancer
Amit Mahipal
, Axel Grothey
Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Role of biologics in first-line treatment of colorectal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Biological Products
100%
Colorectal Neoplasms
80%
Biological Factors
36%
Bevacizumab
25%
Panitumumab
16%
Therapeutics
16%
Cetuximab
14%
Oxaliplatin
13%
Irinotecan
13%
Drug Therapy
13%
Cytotoxins
12%
Age Factors
12%
Survival
12%
Combination Drug Therapy
11%
Epidermal Growth Factor
11%
Neoplasms
10%
Tumor Burden
10%
Vascular Endothelial Growth Factor A
9%
Anti-Idiotypic Antibodies
9%
Decision Making
9%
Comorbidity
8%
Clinical Trials
7%
Biomarkers
7%
Mutation
6%
Antibodies
6%
Social Sciences
cancer
92%
comorbidity
24%
Clinical Trials
21%
scenario
14%
decision making
12%
management
9%